Nanna Therapeutics

Nanna Therapeutics - previously known as Bactevo - is a company that develops novel drugs for age-related diseases. It was founded in 2012 by David Williams. The company was acquired by Astellas Pharma in April 2020 and is now operating as one of its subsidiaries. Nanna Therapeutics is headquartered in Cambridge, England, United Kingdom.

Nanna Therapeutics has a proprietary technology called Totally Integrated Medicines Engine (TIME), which helps accelerate the drug development process by performing successive processes in a parallel manner instead. TIME does this by utilizing artificial intelligence and machine learning to discern molecule datasets. Through their technology, Nanna Therapeutics develops new drug-based treatments for age-related medical conditions ranging from neurodegenerative to cardiovascular diseases. It specifically develops new therapeutics aimed at modulating immuno-regulatory function, repairing DNA, as well as resolving and preventing mitochondrial dysfunction.